Methylphenidate Hydrochloride NDC 10702-102

NDC codes

FDA NDC Directory

Product NDC (as listed)10702-102Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10702-0102Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
10702-102-01	10702010201	100 TABLET in 1 BOTTLE (10702-102-01)Marketed from May 11, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methylphenidate Hydrochloride
Generic name (nonproprietary): methylphenidate hydrochloride
Active ingredients: Methylphenidate hydrochloride — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: KVK-TECH, INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206932
Marketing start: May 11, 2017
Listing expires: Dec 31, 2027
DEA schedule: CII
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)
Identifiers: Product ID 10702-102_476dd35a-34a9-02dd-e063-6394a90a912aSPL ID 476dd35a-34a9-02dd-e063-6394a90a912aSPL set ID 1bf37f9f-29cf-4b09-9c81-eb369e35a042RxCUI 1091150, 1091392, 1091497UNII 4B3SC438HI
Pharmacologic class: Central Nervous System Stimulant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N410702010201 followed by a unit qualifier and the quantity

Package 10702-0102-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 2, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Methylphenidate hydrochloride tablets are indicated for the treatment of: Attention Deficit Hyperactivity Disorders (ADHD) in pediatric patients 6 years and older and adults Narcolepsy Methylphenidate hydrochloride tablets is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorders (ADHD) and Narcolepsy (1).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206932

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206932
Product	Strength	Form · route	Labeler	Product NDC
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 5 mg/1	TabletOral	KVK-TECH, INC.	10702-100
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 10 mg/1	TabletOral	KVK-TECH, INC.	10702-101